This comprehensive survey of recent research sheds light on the health outcomes of vulnerable populations, particularly focusing on extremely preterm infants and the nuanced impacts of maternal pre-pregnancy body mass index (BMI) on infant mortality rates. A multicentre cohort study within the Chinese Neonatal Network, analyzing data from 2494 infants diagnosed with Patent Ductus Arteriosus (PDA), highlights the intricate relationship between PDA treatment and short-term outcomes, revealing a significant reduction in the risk of death with treatment, but with an increased risk of bronchopulmonary dysplasia. Similarly, a retrospective cohort study of over 28 million births in the USA explores the complex associations between maternal BMI and the risk of stillbirth, infant, and neonatal mortality, pinpointing optimal BMI ranges that minimize these risks. Adding to this body of knowledge, a study utilizing data from the National Neonatal Research Database covering neonatal units in England and Wales from 2012 to 2020 investigates the association between opioid use during mechanical ventilation and the risk of brain injury in preterm infants born at <32 weeks' gestational age. Employing a retrospective propensity score-matched cohort design, this research found that 58% of ventilated infants were administered opioids, with an observed increase in the trend over the study period. The analysis indicated that infants exposed to opioids had a higher likelihood of developing brain injuries, with the risk escalating with longer exposure durations. Together, these studies underscore the importance of tailored healthcare strategies—whether in the management of PDA in preterm infants, guiding pre-pregnancy weight management, or cautiously administering opioids to mechanically ventilated preterm infants—to enhance survival outcomes and advocate for a nuanced approach to treatment and care in these sensitive health contexts. The collective findings emphasize the critical need for precision in medical interventions and the consideration of individual patient characteristics to optimize health outcomes in vulnerable populations.